Cargando…
Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies
SIMPLE SUMMARY: Substantial genetic heterogeneity was described within large tumour masses of several cancer entities. However, this topic has not been addressed in patients with diffuse large B-cell lymphoma (DLBCL). Therefore, we collected multiple biopsies of twelve patients who had diagnostic or...
Autores principales: | Magnes, Teresa, Wagner, Sandro, Thorner, Aaron R., Neureiter, Daniel, Klieser, Eckhard, Rinnerthaler, Gabriel, Weiss, Lukas, Huemer, Florian, Schlick, Konstantin, Zaborsky, Nadja, Steiner, Markus, Greil, Richard, Egle, Alexander, Melchardt, Thomas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7914762/ https://www.ncbi.nlm.nih.gov/pubmed/33561953 http://dx.doi.org/10.3390/cancers13040650 |
Ejemplares similares
-
Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence
por: Magnes, T., et al.
Publicado: (2021) -
Correction: The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab
por: Magnes, T., et al.
Publicado: (2019) -
Combination Strategies for Immune-Checkpoint Blockade and Response Prediction by Artificial Intelligence
por: Huemer, Florian, et al.
Publicado: (2020) -
NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients
por: Prochazka, Katharina T, et al.
Publicado: (2016) -
Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy
por: Magnes, Teresa, et al.
Publicado: (2017)